Oryzon Genomics S.A. (0RDB.L)

EUR 1.6

(-4.88%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 118.01 Million 111.03 Million 108.56 Million 114.96 Million 89.84 Million 77.27 Million
Total Current Assets 15.76 Million 26.94 Million 37.11 Million 51.76 Million 42.33 Million 40.85 Million
Cash And Short Term Investments 13.53 Million 22.82 Million 32.69 Million 48.38 Million 39.54 Million 39.31 Million
Cash and Cash Equivalents 13.53 Million 22.82 Million 32.69 Million 48.38 Million 39.38 Million 39.31 Million
Short Term Investments - - - - 158.78 Thousand 636.96
Net Receivables 0.01 0.51 - 1.00 1.00 -
Inventory 6655.99 10.49 Thousand 118.13 Thousand 387.04 Thousand 323.95 Thousand 154.08 Thousand
Other Current Assets 2.22 Million 4.1 Million 4.29 Million 2.99 Million 2.46 Million 1.38 Million
Total Non-Current Assets 102.25 Million 84.09 Million 71.45 Million 63.19 Million 47.51 Million 36.41 Million
Net PPE 531.34 Thousand 654.69 Thousand 776.71 Thousand 786.61 Thousand 708.11 Thousand 761.72 Thousand
Good Will And Intangible Assets 420.95 Thousand 557.25 Thousand 717.5 Thousand 253.59 Thousand 505.09 Thousand 137.3 Thousand
Good Will - - - - - -
Intangible Assets 420.95 Thousand 557.25 Thousand 717.5 Thousand 253.59 Thousand 505.09 Thousand 137.3 Thousand
Long-Term Investments - - - 49.84 Thousand 45.76 Thousand 46.74 Thousand
Tax Assets - - - 1.00 1.00 1.00
Other Non Current Assets 101.3 Million 82.88 Million 69.95 Million 62.1 Million 46.25 Million 35.46 Million
Other Assets - - 1.00 1.00 1.00 -
Total Liabilities 27.73 Million 33.33 Million 27.45 Million 22.2 Million 21.27 Million 25.57 Million
Total Current Liabilities 18.12 Million 20.05 Million 9.86 Million 9.39 Million 11.82 Million 11.96 Million
Account Payables 3.76 Million 5.42 Million 3.31 Million 2.44 Million 3.65 Million 1.84 Million
Tax Payables - - - - - -
Short Term Debt 13.15 Million 13.03 Million 4.74 Million 5.92 Million 7.34 Million 9.45 Million
Deferred Revenue 687.86 Thousand 1.00 1.00 - 1.00 -
Other Current Liabilities 506.7 Thousand 1.59 Million 1.81 Million 1.01 Million 826.87 Thousand 670 Thousand
Total Non Current Liabilities 9.61 Million 13.27 Million 17.58 Million 12.8 Million 9.44 Million 13.61 Million
Long-Term Debt 6.93 Million 10.99 Million 15.19 Million 10.6 Million 7.51 Million 11.43 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.68 Million 2.27 Million 2.38 Million 2.2 Million 1.93 Million 2.18 Million
Other Liabilities - - 1.00 - 1.00 -
Total Equity 90.27 Million 77.7 Million 81.1 Million 92.75 Million 68.56 Million 51.69 Million
Stock Holders Equity 90.27 Million 77.7 Million 81.1 Million 92.75 Million 68.56 Million 51.69 Million
Common Stock 3.37 Million 2.97 Million 3.01 Million 3.24 Million 2.56 Million 2.24 Million
Retained Earnings -17.24 Million -13.13 Million -9.15 Million -4.09 Million -21.82 Million -18.18 Million
Accumulated other comprehensive income 2.76 Million 3.21 Million 3.84 Million 4.1 Million -1.33 Million 76.07 Thousand
Common Stock Equity 90.27 Million 77.7 Million 81.1 Million 92.75 Million 68.56 Million 51.69 Million
Capital Lease Obligation 86.8 Thousand 106.1 Thousand - - - -
Total Investments - - - 49.84 Thousand 204.54 Thousand 47.37 Thousand
Total Debt 20.08 Million 24.02 Million 19.94 Million 16.53 Million 14.85 Million 20.88 Million
Net Debt 6.55 Million 1.2 Million -12.75 Million -31.84 Million -24.52 Million -18.43 Million

Balance Sheet Charts